Video

Dr. Woloszynska on the Need to Assess Biological Factors of Racial Disparities in Prostate Cancer

Anna Woloszynska, PhD, discusses the need to assess biological factors of racial disparities in prostate cancer.

Anna Woloszynska, PhD, associate professor of oncology, Department of Pharmacology and Therapeutics, Roswell Park Comprehensive Cancer Center, graduate faculty member, State University of New York (SUNY) at Buffalo, discusses the need to assess biological factors of racial disparities in prostate cancer.

Racial disparities in prostate cancer have become a topic of interest because they represent a serious public health issue, Woloszynska says. Moreover, it is important to look at this issue in detail from a biological perspective, which hasn’t been sufficiently done to date, Woloszynska adds.

As research on these topics progresses, it is important to look at racial health disparities in African American men with prostate cancer to identify what the biological determinants of the disease, Woloszynska continues. Future research efforts examine why African American men tend to develop prostate cancer earlier in their lifetime compared with European American men, as well as why African American men often present with more aggressive disease at the time of diagnosis, Woloszynska concludes.

Related Videos
Viktor Grünwald, MD, PhD
Aaron Gerds, MD
Christine M. Lovly, MD, PhD, Ingram Associate Professor of Cancer Research, associate professor, medicine (hematology/oncology), Vanderbilt-Ingram Cancer Center
Haeseong Park, MD, MPH
David L. Porter, MD
Timothy Yap, MBBS, PhD, FRCP
Leo I. Gordon, MD, Abby and John Friend Professor of Oncology Research, professor, medicine (hematology and oncology), Feinberg School of Medicine, Robert H. Lurie Cancer Center
Hetty E. Carraway, MD, MBA, staff associate professor, Department of Medicine, School of Medicine, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University; member, Immune Oncology Program, Case Comprehensive Cancer Center; vice chair, Strategy and Enterprise Development, Taussig Cancer Institute, Division of Hematologic Oncology and Blood Disorders, Cleveland Clinic
David A. Braun, MD, PhD, assistant professor, medicine (medical oncology), Louis Goodman and Alfred Gilman Yale Scholar, member, Center of Molecular and Cellular Oncology, Yale Cancer Center
Julia Foldi, MD, PhD